June 13, 2019 – Modern Veterinary Therapeutics, LLC announces today that the Veterinary Drugs Directorate (VDD) has approved DexvetidineTM (dexmedetomidine injection – 0.5mg/mL) in Canada. DexvetidineTM, presented in a 10mL vial, is indicated for use as a sedative and analgesic in dogs and cats to facilitate clinical examinations, clinical procedures, minor surgical procedures, and minor dental procedures. DexvetidineTM is also indicated for use as a preanesthetic to general anesthesia in dogs and cats. “Modern Veterinary Therapeutics, LLC is pleased to announce this new approval in Canada which further expands our veterinary line of sedative and analgesic products,” said Dr. Cuong Tu Ba, President of Modern Veterinary Therapeutics, LLC.
